Development of two TaqMan real-time reverse transcription-PCR assays for the detection of severe acute respiratory syndrome coronavirus-2Highlights

The outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, was caused by a novel coronavirus (CoV), named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The rapid detection of viral nucleic acids is critical for the early identification of infected cases. We have developed t...

Full description

Saved in:
Bibliographic Details
Main Authors: Yiwei Liu (Author), Yingying Wang (Author), Xinming Wang (Author), Yan Xiao (Author), Lan Chen (Author), Li Guo (Author), Jianguo Li (Author), Lili Ren (Author), Jianwei Wang (Author)
Format: Book
Published: Elsevier, 2020-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_cb9b20e268a143ecaaec2b272cd3cc4f
042 |a dc 
100 1 0 |a Yiwei Liu  |e author 
700 1 0 |a Yingying Wang  |e author 
700 1 0 |a Xinming Wang  |e author 
700 1 0 |a Yan Xiao  |e author 
700 1 0 |a Lan Chen  |e author 
700 1 0 |a Li Guo  |e author 
700 1 0 |a Jianguo Li  |e author 
700 1 0 |a Lili Ren  |e author 
700 1 0 |a Jianwei Wang  |e author 
245 0 0 |a Development of two TaqMan real-time reverse transcription-PCR assays for the detection of severe acute respiratory syndrome coronavirus-2Highlights 
260 |b Elsevier,   |c 2020-12-01T00:00:00Z. 
500 |a 2590-0536 
500 |a 10.1016/j.bsheal.2020.07.009 
520 |a The outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, was caused by a novel coronavirus (CoV), named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The rapid detection of viral nucleic acids is critical for the early identification of infected cases. We have developed two TaqMan real-time reverse transcription-PCR assays to detect SARS-CoV-2. The designed primers target the nucleocapsid (N) and open reading frame (ORF) 1b gene regions, where the probes discriminate SARS-CoV-2 from other human and animal CoVs. The sensitivities are one genomic copy per reaction for the N gene assay and ten copies for the ORF 1b gene assay. The overall linear detection ranges are 1-106 and 10-106 copies per reaction for the N gene assay and the ORF 1b gene assay, respectively. Surveillance of 23 suspected COVID-19 patients demonstrated that SARS-CoV-2 could be detected from 100% (23/23) and 62.5% (16/23) of clinical specimens by the N gene assay and the ORF 1b gene assay, respectively. All of the samples not detected by the ORF 1b gene assay were throat swabs, indicating a lower viral load in the upper respiratory tract and the relatively lower sensitivity of the ORF 1b gene assay. The assays developed in the present study offer alternative diagnostic tests for COVID-19. 
546 |a EN 
690 |a SARS-CoV-2 
690 |a Real-time RT-PCR 
690 |a Nucleocapsid 
690 |a Open reading frame 1b 
690 |a Infectious and parasitic diseases 
690 |a RC109-216 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Biosafety and Health, Vol 2, Iss 4, Pp 232-237 (2020) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S2590053620300823 
787 0 |n https://doaj.org/toc/2590-0536 
856 4 1 |u https://doaj.org/article/cb9b20e268a143ecaaec2b272cd3cc4f  |z Connect to this object online.